Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer.

Rud AK, Lund-Iversen M, Berge G, Brustugun OT, Solberg SK, Mælandsmo GM, Boye K.

BMC Cancer. 2012 Aug 1;12:333.

2.

Osteopontin is a prognostic biomarker in non-small cell lung cancer.

Rud AK, Boye K, Oijordsbakken M, Lund-Iversen M, Halvorsen AR, Solberg SK, Berge G, Helland A, Brustugun OT, Mælandsmo GM.

BMC Cancer. 2013 Nov 11;13:540. doi: 10.1186/1471-2407-13-540.

3.

Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.

Ishikawa M, Miyahara R, Sonobe M, Horiuchi M, Mennju T, Nakayama E, Kobayashi M, Kikuchi R, Kitamura J, Imamura N, Huang CL, Date H.

Lung Cancer. 2012 Jun;76(3):431-8. doi: 10.1016/j.lungcan.2011.12.004.

PMID:
22236865
4.

[Correlations of S100A4 protein expression to invasion and metastasis of non-small cell lung cancer].

Chen XL, Zhang WG, Chen XY, Sun ZM, Liu SH.

Ai Zheng. 2006 Sep;25(9):1134-7. Chinese.

PMID:
16965657
5.

Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene.

Sukka-Ganesh B, Mohammed KA, Kaye F, Goldberg EP, Nasreen N.

BMC Cancer. 2012 Jul 23;12:309. doi: 10.1186/1471-2407-12-309.

6.
7.

[Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer].

Chen XL, Wang LC, Zhang WG, Chen XY, Sun ZM.

Nan Fang Yi Ke Da Xue Xue Bao. 2008 Jul;28(7):1254-8. Chinese.

8.

High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.

Wang YY, Ye ZY, Zhao ZS, Tao HQ, Chu YQ.

Ann Surg Oncol. 2010 Jan;17(1):89-97. doi: 10.1245/s10434-009-0722-z.

PMID:
19820999
9.

Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis.

Berge G, Pettersen S, Grotterød I, Bettum IJ, Boye K, Mælandsmo GM.

Int J Cancer. 2011 Aug 15;129(4):780-90. doi: 10.1002/ijc.25735.

10.

Activation of NF-kappaB by extracellular S100A4: analysis of signal transduction mechanisms and identification of target genes.

Boye K, Grotterød I, Aasheim HC, Hovig E, Maelandsmo GM.

Int J Cancer. 2008 Sep 15;123(6):1301-10. doi: 10.1002/ijc.23617.

11.

S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.

Zhao Y, Zhang T, Wang Q.

Oncol Rep. 2013 Jul;30(1):111-8. doi: 10.3892/or.2013.2419.

PMID:
23612849
12.

Enhanced S100A4 protein expression is clinicopathologically significant to metastatic potential and p53 dysfunction in colorectal cancer.

Kim JH, Kim CN, Kim SY, Lee JS, Cho D, Kim JW, Yoon SY.

Oncol Rep. 2009 Jul;22(1):41-7.

PMID:
19513503
13.

Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes.

Matsubara D, Niki T, Ishikawa S, Goto A, Ohara E, Yokomizo T, Heizmann CW, Aburatani H, Moriyama S, Moriyama H, Nishimura Y, Funata N, Fukayama M.

Cancer Sci. 2005 Dec;96(12):844-57.

14.

Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.

Zhang H, Liu J, Yue D, Gao L, Wang D, Zhang H, Wang C.

J Clin Pathol. 2013 Nov;66(11):937-45. doi: 10.1136/jclinpath-2013-201467.

PMID:
23853314
15.

Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.

Huang Q, Fan J, Qian X, Lv Z, Zhang X, Han J, Wu F, Chen C, Du J, Guo M, Hu G, Jin Y.

J Cancer Res Clin Oncol. 2016 Jan;142(1):263-72. doi: 10.1007/s00432-015-2040-0.

PMID:
26319393
16.

Functional heterogeneity of osteopontin isoforms in non-small cell lung cancer.

Goparaju CM, Pass HI, Blasberg JD, Hirsch N, Donington JS.

J Thorac Oncol. 2010 Oct;5(10):1516-23. doi: 10.1097/JTO.0b013e3181eba6bd.

17.

Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer.

Kimura K, Endo Y, Yonemura Y, Heizmann CW, Schafer BW, Watanabe Y, Sasaki T.

Int J Oncol. 2000 Jun;16(6):1125-31.

PMID:
10811984
18.

Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.

Sack U, Walther W, Scudiero D, Selby M, Kobelt D, Lemm M, Fichtner I, Schlag PM, Shoemaker RH, Stein U.

J Natl Cancer Inst. 2011 Jul 6;103(13):1018-36. doi: 10.1093/jnci/djr190.

19.

Significance of S100A4 as a prognostic marker of lung squamous cell carcinoma.

Tsuna M, Kageyama S, Fukuoka J, Kitano H, Doki Y, Tezuka H, Yasuda H.

Anticancer Res. 2009 Jul;29(7):2547-54.

20.

Hypomethylation-induced expression of S100A4 in endometrial carcinoma.

Xie R, Loose DS, Shipley GL, Xie S, Bassett RL Jr, Broaddus RR.

Mod Pathol. 2007 Oct;20(10):1045-54.

Items per page

Supplemental Content

Support Center